Exelixis Inc at JMP Securities Hematology Oncology Summit (Virtual) Transcript
Welcome to day 2 of our Annual JMP Oncology -- Hematology and Oncology Conference. Thanks for joining us. My name is Silvan Tuerkcan. I'm a senior analyst here at JMP Citizens covering precision medicines.
If you would like to ask a question anytime during today's discussion, please e-mail me or submit them via the chat.
Today, right now, it's my pleasure to host CSO, Peter Lamb and Andrew Peters, Senior Vice President of Strategy of Exelixis. Thank you so much for joining us today.
Yes. Thanks for having us.
Questions & Answers
So obviously, regarding your cash flow generating commercial capital franchise, you're on track to hit the topline of your guidance. And you've -- I'm sure we've been talking a lot about the continuous growth of the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
